1.
Papp K, Szepietowski JC, Kircik L, Toth D, Kuligowski ME, Venturanza ME, Sun K, Simpson EL. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. J of Skin [Internet]. 2020Oct.27 [cited 2022Jul.1];4(6):s95. Available from: https://www.jofskin.org/index.php/skin/article/view/1065